148 related articles for article (PubMed ID: 26797634)
1. Reactive Oxygen Species as Additional Determinants for Cytotoxicity of Clostridium difficile Toxins A and B.
Frädrich C; Beer LA; Gerhard R
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26797634
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins.
Nusrat A; von Eichel-Streiber C; Turner JR; Verkade P; Madara JL; Parkos CA
Infect Immun; 2001 Mar; 69(3):1329-36. PubMed ID: 11179295
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of Clostridium difficile toxin A.
Chumbler NM; Rutherford SA; Zhang Z; Farrow MA; Lisher JP; Farquhar E; Giedroc DP; Spiller BW; Melnyk RA; Lacy DB
Nat Microbiol; 2016 Jan; 1():15002. PubMed ID: 27571750
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infection: a review of current and emerging therapies.
Ofosu A
Ann Gastroenterol; 2016; 29(2):147-54. PubMed ID: 27065726
[TBL] [Abstract][Full Text] [Related]
5. Adverse events in faecal microbiota transplant: a review of the literature.
Baxter M; Colville A
J Hosp Infect; 2016 Feb; 92(2):117-27. PubMed ID: 26803556
[TBL] [Abstract][Full Text] [Related]
6. Breakthroughs in the treatment and prevention of Clostridium difficile infection.
Kociolek LK; Gerding DN
Nat Rev Gastroenterol Hepatol; 2016 Mar; 13(3):150-60. PubMed ID: 26860266
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.
Chen S; Gu H; Sun C; Wang H; Wang J
Infection; 2017 Jun; 45(3):255-262. PubMed ID: 27601055
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.
Di Bella S; Ascenzi P; Siarakas S; Petrosillo N; di Masi A
Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27153087
[TBL] [Abstract][Full Text] [Related]
9. Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.
Shin JH; High KP; Warren CA
J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):916-22. PubMed ID: 26809495
[TBL] [Abstract][Full Text] [Related]
10. An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection.
Antharam VC; McEwen DC; Garrett TJ; Dossey AT; Li EC; Kozlov AN; Mesbah Z; Wang GP
PLoS One; 2016; 11(2):e0148824. PubMed ID: 26871580
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.
Spigaglia P
Ther Adv Infect Dis; 2016 Feb; 3(1):23-42. PubMed ID: 26862400
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.
Ghose C; Eugenis I; Sun X; Edwards AN; McBride SM; Pride DT; Kelly CP; Ho DD
Emerg Microbes Infect; 2016 Feb; 5(2):e8. PubMed ID: 26839147
[TBL] [Abstract][Full Text] [Related]
13. Oscillating behavior of Clostridium difficile Min proteins in Bacillus subtilis.
Makroczyová J; Jamroškovič J; Krascsenitsová E; Labajová N; Barák I
Microbiologyopen; 2016 Jun; 5(3):387-401. PubMed ID: 26817670
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Bacteria Other Than Clostridium difficile in Antibiotic-Associated Diarrhoea.
Larcombe S; Hutton ML; Lyras D
Trends Microbiol; 2016 Jun; 24(6):463-476. PubMed ID: 26897710
[TBL] [Abstract][Full Text] [Related]
15. Host-Microbiota Interactions in the Pathogenesis of Antibiotic-Associated Diseases.
Lichtman JS; Ferreyra JA; Ng KM; Smits SA; Sonnenburg JL; Elias JE
Cell Rep; 2016 Feb; 14(5):1049-1061. PubMed ID: 26832403
[TBL] [Abstract][Full Text] [Related]
16. Peripheral Neuropathy After Fecal Microbiota Transplantation for Clostridium difficile Infection: A Case Report.
Didesch MM; Averill A; Oh-Park M
PM R; 2016 Aug; 8(8):813-6. PubMed ID: 26826616
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural Variability of the Exosporium Layer of Clostridium difficile Spores.
Pizarro-Guajardo M; Calderón-Romero P; Castro-Córdova P; Mora-Uribe P; Paredes-Sabja D
Appl Environ Microbiol; 2016 Feb; 82(7):2202-2209. PubMed ID: 26850296
[TBL] [Abstract][Full Text] [Related]
18. Bacterial probiotics as an aid in the control of Clostridium difficile disease in neonatal pigs.
Arruda PH; Madson DM; Ramirez A; Rowe EW; Songer JG
Can Vet J; 2016 Feb; 57(2):183-8. PubMed ID: 26834271
[TBL] [Abstract][Full Text] [Related]
19. A multi-laboratory comparison of two molecular methods for the detection of toxigenic Clostridium difficile.
Halstead DC; Abid J; Sloan L; Meza D; Ramsey-Walker D; Hata DJ
J Infect Dev Ctries; 2016 Jan; 10(1):62-7. PubMed ID: 26829538
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
